日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

[Clinical characteristics and prognosis analysis in patients with bone marrow invasive follicular lymphoma]

【骨髓浸润性滤泡性淋巴瘤患者的临床特征及预后分析】

期刊:Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
影响因子:
doi:10.3760/cma.j.cn121090-20240613-00222
Lyu, R; Xiong, W J; Wang, T Y; Yan, Y T; Wang, Q; Yu, Y; Liu, W; Huang, W Y; An, G; Xu, Y; Zou, D H; Qiu, L G; Yi, S H
淋巴瘤
发表日期：2024
文献求助 收藏

[The efficacy and safety of ibrutinib in the treatment of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia]

[伊布替尼治疗淋巴浆细胞淋巴瘤/华氏巨球蛋白血症的疗效和安全性]

期刊:Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
影响因子:
doi:10.3760/cma.j.cn121090-20240301-00077
Huang, Y S; Xiong, W J; Yuan, J J; Yu, Y; Li, Y X; Yan, Y T; Wang, T Y; Lyu, R; Liu, W; An, G; Zhao, Y Z; Zou, D H; Qiu, L G; Yi, S H
细胞生物学
淋巴瘤
发表日期：2024
文献求助 收藏

Challenges of the COVID-19 Pandemic: Experiences from South Korea and Taiwan

新冠疫情带来的挑战：来自韩国和台湾的经验

期刊:Journal of Asian and African Studies
影响因子:0.9
doi:10.1177/00219096221136944
Wang, T Y
微生物学
新冠
发表日期：2023
文献求助 收藏

[Gray zone lymphoma: five cases report and literature review]

【灰色地带淋巴瘤：5例病例报告及文献复习】

期刊:Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
影响因子:
doi:10.3760/cma.j.issn.0253-2727.2023.03.011
Zou, H S; Zhang, H J; Liu, H M; Huang, W Y; Liu, W; Lyu, R; Wang, T Y; Sui, W W; Fu, M W; Wang, Q; Qiu, L G; Zou, D H
淋巴瘤
发表日期：2023
文献求助 收藏

[Clinical characteristics of 11 patients with chronic lymphocytic leukemia with t (14;19) (q32;q13)]

[11例伴有t(14;19)(q32;q13)的慢性淋巴细胞白血病患者的临床特征]

期刊:Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
影响因子:
doi:10.3760/cma.j.issn.0253-2727.2023.05.011
Cui, C H; Chang, Y N; Zhou, J; Li, C W; Wang, H J; Sun, Q; Jia, Y J; Li, Q H; Wang, T Y; Qiu, L G; Yi, S H
细胞生物学
白血病
发表日期：2023
文献求助 收藏

[A prospective clinical trial of TCD-induced regimen for symptomatic Waldenström macroglobulinemia]

[一项针对症状性华氏巨球蛋白血症的经颅多普勒超声诱导疗法的前瞻性临床试验]

期刊:Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
影响因子:
doi:10.3760/cma.j.issn.0253-2727.2023.08.012
Huang, Y S; Xiong, W J; Yu, Y; Yan, Y T; Wang, T Y; Lyu, R; Liu, W; An, G; Zhao, Y Z; Zou, D H; Qiu, L G; Yi, S H
发表日期：2023
文献求助 收藏

[Efficacy and safety of programmed death-1 inhibitor in the treatment of relapsed/refractory classical Hodgkin's lymphoma]

[程序性死亡受体-1抑制剂治疗复发/难治性经典霍奇金淋巴瘤的疗效和安全性]

期刊:Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
影响因子:
doi:10.3760/cma.j.issn.0253-2727.2023.07.005
Shan, D D; Liu, H M; Liu, W; Huang, W Y; Lyu, R; Deng, S H; Yi, S H; An, G; Xu, Y; Sui, W W; Wang, T Y; Fu, M W; Zhao, Y Z; Qiu, L G; Zou, D H
信号转导
淋巴瘤
发表日期：2023
文献求助 收藏

[Dose-enhanced immunochemotherapy followed by first-line autologous peripheral blood stem cell transplantation for young patients with high-risk aggressive B-cell lymphoma: an efficacy and prognostic factor analysis]

[剂量增强免疫化疗联合一线自体外周血干细胞移植治疗高危侵袭性B细胞淋巴瘤年轻患者的疗效及预后因素分析]

期刊:Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
影响因子:
doi:10.3760/cma.j.issn.0253-2727.2022.03.006
Wang, Y; Liu, W; Huang, W Y; Lyu, R; Li, J; Deng, S H; Sui, W W; Liu, H; Wang, T Y; Yi, S H; Liu, H M; Qiu, L G; Zou, D H
干细胞
发育与干细胞
免疫/内分泌
B细胞
淋巴瘤
细胞生物学
发表日期：2022
文献求助 收藏

[Large B-cell lymphoma with IRF4 rearrangement: six case reports and a literature review]

[伴有IRF4重排的大B细胞淋巴瘤：6例病例报告及文献综述]

期刊:Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
影响因子:
doi:10.3760/cma.j.issn.0253-2727.2022.06.006
Yu, Y; Sun, Q; Li, C W; Jia, Y J; Liu, W; Wang, T Y; Lyu, R; Yan, Y T; An, G; Qiu, L G; Zou, D H; Yi, S H
淋巴瘤
细胞生物学
B细胞
免疫/内分泌
发表日期：2022
文献求助 收藏

[Research progress on the relationship between liver cirrhosis and thyroid hormones]

【肝硬化与甲状腺激素关系的研究进展】

期刊:Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
影响因子:
doi:10.3760/cma.j.cn501113-20210508-00225
Zheng, M Y; He, Y J; Liu, X Y; Zhang, Q H; Wang, T Y; Yang, J L; Shu, J C
肝硬化
免疫/内分泌
发表日期：2022
文献求助 收藏